Medical Press Release - Page 7 of 12 - Medika Life : Keeping you informed

Alterity has secured the worldwide exclusive right to patented technology to develop and commercialise therapies that re-sensitise bacteria to antibiotics

Claims Conference Secures $13.5 Million In Funding To Get Holocaust Survivors To Vaccine Sites

Medika Life - March 24, 2021

A New Program, Established by The Claims Conference and Funded by The German Government, Will Ensure Holocaust Survivors Globally Have the Means to Get To COVID-19 Vaccine Sites

Opdivo® Approved for the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Medika Life - August 6, 2020

FDA Approved Opdivo demonstrated superior overall survival benefit compared to docetaxel or paclitaxel in ESCC Patients

Children with no COVID-19 symptoms may shed virus for weeks

Medika Life - August 30, 2020

New research suggests that children can shed SARS-CoV-2, the virus that causes COVID-19, even if they never develop symptoms or for long after symptoms have cleared

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

LATEST

TRENDING

Medika’s Call for Food Aid for Starving Filipino Children

Lover, the App That Helps Women Reach Orgasm

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

The 50 Most Influential Leaders in Pharmacy 2022 Awards

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

FINN Partners Brings Aboard the Pharmacy Podcast Network

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

South University Announces New MSPA Program at West Palm Beach Campus

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

EDITORS CHOICE

Alterity and UniQuest Partner to Reverse Bacterial Resistance to Antibiotics

Claims Conference Secures $13.5 Million In Funding To Get Holocaust Survivors To Vaccine Sites

Opdivo® Approved for the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Children with no COVID-19 symptoms may shed virus for weeks

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories